 Vaccinex Inc NASDAQ: VCNX jumps premarket in reaction to multi-project deals signed with two undisclosed prominent pharmaceutical companies, utilizing Vaccinexs ActivMAb, antibody discovery, and novel viral display platform for antibody discovery against complex antigens such as GPCRs and ion channels. The financial terms of the deals were not disclosed. 